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Dose Dependency of Aflatoxin B1 Binding
on Human High Molecular Weight DNA in
The Activation of Proto-Oncogene
by Stringner S. Yang,* Janet V. Taub,* Rama Modali,*
Wilfred Vieira,t Parvin Yasei,* and George C. Yang*
The binding ofaflatoxin B1, AFB1, a potent hepatocarcinogen, to various high molecular weight (HMW)
DNAs from human normal liver and two liver cancer cell lines, Alexander primary liver carcinoma (PLC)
and Mahlavu hepatocellular carcinoma (hHC) and from NIH/3T3 cell have been investigated. The kinetics
of AFB1 binding to these DNAs showed similar initial rates but the extents of binding to the PLC and
hHC DNAs seemed to be slightly higher. Preferential AFB1 bindings were identified in both PLC and hHC
DNAs compared to normal liver DNA when analyzed by restriction endonuclease digestions and agarose
gel electrophoresis. AcriticalAFB1 bindingdosage, ranging 100to460fmole/,Lg DNA, wasfoundtoactivate
the carcinogenic effect of the Mahlavu hHC HMW DNA, but not normal liver HMW DNA, rendering it
capable of inducing focal transformation in NIH/3T3 cell. Excessive AFB1 binding on the hHC and PLC
HMW DNAs resulted in an "over-kill" of both cell transformation capability and templating activity of
the DNA.
Introduction
The highly carcinogenic agents are frequently also
potent mutagens (1). Their insults are often directed at
macromolecules such as DNA generating modifications
by way of chemical interactions that result in lethal
lesions or codon alteration(s) similar to (point) muta-
tions. Aflatoxin B1 (AFB1), a metabolite ofAspergillus
flavus, is well known for its potency in hepatocarcino-
genesis in numerous animal species includingtrout, rat,
hamster, dog, and rhesus monkey (2). AFB1 has also
been implicated in the etiology of human liver cancer
on the basis of significant statistical correlations be-
tween the increased occurrence of liver cancer in areas
of Asia and Africa and the consumption of grains con-
taminated with AFB1 (3-5). Furthermore AFB1 was
reportedly detected in human liver cancer tissue sam-
ples (5,6). In the experimental animal, AFB1 was found
to be activated by microsomal mixed-function oxidases
in liver cells to form AFB,-2,3-epoxide (7), which then
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bound to the N7 of guanine in both DNA and RNA
leading to adduct formation (7,8). More recently, it has
been reported that by using monoclonal antibody spe-
cific against AFB1-DNA adduct, AFB1-DNA adducts
were detected in human urine samples and in liver bi-
opsy samples obtained from patients (9). In fibroblast
tissue culture AFB1 has to be activated before it can
act as a tumor initiator in conjunction with TPA, the
tumor promotor, and is known to induce mutation in
Chinese hamstercells and transformC3H/1OT1/2 mouse
fibroblasts (10). The ability of AFB1 to react with the
cell's DNA in adduct formation thus depends on the
activation of AFB1 to its reactive form by the cellular
microsomal peroxidase such as inthe liver cell. In order
to understand the molecular mechanism in which AFB1
induces the process ofhepatocarcinogenesis, it requires
precise analysis on the binding affinity of AFB, with
humanliver DNA, the possibility ofpreferential targets
within the genomic DNA as well as the genomic nature
of the targeted DNA. In this investigation we have
examined the formation of adducts between 3H-labeled
AFB1 with several human DNA samples derived from
Alexander primary hepatocellular carcinoma (PLC),
Mahlavu hepatocellular carcinoma (hHC), and a normal
adult liver sample by agarose gel electrophoresis.
The DNA fragments, preferentially targeted by AFB,YANG ET AL.
were also defined by restriction endonuclease analysis.
The biological activity of AFB,-bound high molecular
weight (HMW) DNAs with respect to (1) DNA-me-
diated cell transformation by transfection and (2) the
templating efficiency oftheAFB,-bound DNAs in DNA
polymerase assay was also analyzed.
Materials and Methods
Tissues and Cell Cultures
A normal adult liver (NAL) from a young adult was
fresh tissue kindly provided by Dr. A. Huang, Fairfax
Hospital, VA. (Alexander) PLC is human primary he-
patocellular carcinoma currently maintained in tissue
culture. It carries the hepatitis B marker. MAH, Mah-
lavu hepatocellular carcinoma, is a tissue culture cell
line recently established from a hepatocellular carci-
noma obtained from an African patient. NIH/3T3 is a
mouse fibroblast cell line kindly provided by Dr. D.
Lowy ofthe National Cancer Institute (Bethesda, MD).
Cells in culture are maintained in Dulbecco modified
Eagle's media supplemented with 10% fetal calf serum
(560C, 30 min) plus penicillin (50 units/mL) and strep-
tomycin (25 ,ug/mL) in a 5% CO2 atmosphere at 37°C.
All tissue culture materials were purchased from GIBCO
(Grand Island, NY), and Microbiological Associates (Be-
thesda, MD).
DNA Preparation and AFB1 Binding
Reaction
Total and high molecular weight DNA was prepared
from fresh liver tissue, minced and homogenized, or
from frozen liver afterpulverization in liquid N2 or from
tissue culture cellsinlysingbuffercontainingproteinase
K (final concentration, 75 ,ug/mL), 50 mM Tris-HCI, pH
8.1, 1 mM EDTA, and 1% SDS, at 37°C for 2 hr as
described earlier (11). The preparations were then pur-
ified by sequential phenol-cresol, chloroform-isoamyl
alcohol, and etherextractions followedbyethanol-NaCl
precipitation at -20°C overnight. The DNA samples were
then further purified by RNase digestion followed by a
second sequence ofphenol-cresol, chloroform-isoamyl
alcohol, and ether extractions and ethanol-NaCl pre-
cipitation. When needed, the DNA samples were fur-
ther banded by cesium chloride gradient centrifugation
at 50,000 rpm for 18 hrs. The DNA samples were then
dialyzed against Tris-HCl, 20 mM, EDTA, 1 mM, and
NaCl, 0.1 M (TEN buffer) exhaustively prior to their
use in experiments.
[3H]AFB1 was purchased from Morovak Laboratory,
CA, at 15 Ci/mmole. It was further purified by HPLC
and the resultant single peak of[3H]-AFB, had the spe-
cific activity of 9250 cpm/pmole in chloroform. The pro-
cedure for [3H]AFB1 binding to DNA was as described
earlier (8,12). Briefly, [3H]AFB1 was first activated either
by incubation with microsomal oxidase preparation or
chemically with perchlorobenzoic acid and methylene
chloride to the epoxide form priorto its interaction with
DNA. Kinetics ofthe [3H]AFB1-DNAadductformation
was determined by withdrawing 25 ,uL samples at spec-
ified intervals and precipitating onto nitrocellulose fil-
ters in 10% trichloracetic acid at 0°C, followed by 10
washes ofeach filterwith chloroform, 1.5mL eachtime.
The filters bearing the [3H]AFB1-DNA adduct were
dried and counted by a liquid scintillation method. Si-
multaneously 250 ,uL [3H]AFB1-DNA samples were
withdrawn and purified by alcohol precipitation until no
free [3H]AFB,-DNA can be detected. They were fur-
ther extensively washed with chloroform prior to their
use in analyses by agarose gel electrophoresis after re-
striction enzyme digestions, or by DNA-mediated cell-
transformation assays.
Agarose Gel Electrophoresis and
Restriction Endonuclease Analysis of
[3H]AFB1-DNA
Purified [3H]-AFB1-DNA was analyzed by agarose
gel electrophoresis with or without digestions with the
following restriction endonucleases: Eco RI, Bam HIl,
Hind III, Pst I, Kpn I, Alu I, Hae III, and Taq I. The
conditions for the assay reactions of the numerous re-
striction endonucleases were as described in the pro-
cedures provided by the various laboratories (New
England Biolab, Beverly, MA; International Biotech-
nology Institute, New Haven, CT; Bethesda Research
Laboratory, Rockville, MD). All reactions were carried
to completion. The [3H]AFB1-DNA fragments were
purified by phenol extraction and a rapid ethanol pre-
cipitation at 0°C prior to analysis by agarose gel elec-
trophoresis. Agarose gel electrophoresis was carried
out with 1% agarose at 50 V for 6 hr as described (11).
The gel was scanned forrelative DNA concentration by
absorbency at 260 m,u. It was then fractionated into 40
to 50 samples andtheradioactivity determined. In some
experiments the agarose gel was treated in Enhance
(New England Nuclear, Boston, MA), rehydrated, dried,
andfluorography taken. Recovery ofDNAfromagarose
gel was carried out by electroelution (11).
Cell-Transformation Assay by DNA
Transfection
Transfection of NIH/3T3 cells with purified HMW
DNA was carried out as described elsewhere (13).
Briefly, human HMW DNAs, isolated and purified from
Mahlavu hepatocellular carcinoma cells (hHC DNA), and
other HMW DNAs prepared from other sources, such
as NIH/3T3 cells and normal adultliver, with orwithout
[H3]AFB1 activation at varying doses, were used to
transfect 105 NIH/3T3 cells. After24hr, the transfected
culture was trypzinized and divided into two plates. As
an option TPA, a tumor promoting agent, was added to
one of the two daughter cultures at optimal concentra-
tion, 0.1 ,ug/mL, for3 days. The cultures werefed every
3 days. Scoring of cell transformation was carried out
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on day 9, 21, and 30 forfocus formingunit. Transformed
foci were cloned out by penny-cylinder trypsinization.
The DNAs were extracted andpurified fromeach trans-
formed clone or from transfected cultures for Southern
blot hybridization against [32p] nick-translated HMW
hHC DNA forverification ofthe integration ofthe hHC
DNA as described below.
DNA-DNA Hybridization Analysis and
Preparation of [32p] Nick-Translated hHC
DNA Probe
High molecular weight DNAs extracted and purified
from various cloned, transformed cells were digested
with numerous restriction endonucleases and analyzed
in 0.8% or 1.0% agarose gel electrophoresis. DNA sam-
ples in the gel was transferred onto nitrocellulose filter
(Schleicher & Schuell, Keene, NH)bythe Southern blot
method (11). Filter hybridization was carried out as
described earlier (11) in stringent conditions, with [32P]
nick-translated human HMW DNA at 106 cpm/mL in
Deinhardt solution at 37°C for 24 hr. The filter was
washed stringently and exhaustively prior to fluoro-
graphy. Mahlavu hHC DNA was extensively purified
as described above andthensubjected toHind III diges-
tion for 2 hr prior to nick-translation with [32P]dGTP
(3000 Ci/mm; Amersham, Arlington Hts., IL), three
other cold deoxynucleoside triphosphates, E. coli Po-
lymerase I, and DNase (11). The [3P]-hHC DNA was
then precipitated, washed, redissolved in 1/10 Ten buffer,
and dialyzed extensively prior to its use as a probe.
Tumorigenesis
Tumorigenicity of the cloned transformed cells and
other transfected cultures that showed no transformed
foci were analyzed by inoculating 106 viable cells into
nude mice. Secondary passage oftumor was carried out
in both NIH Swiss and Balb/c mice for further verifi-
cation. DNAs were also prepared from each tumor for
Southern blot hybridization against [32p] nick-trans-
lated HMW hHC DNA.
DNA Polymerase Assay
DNA polymerase assay was carried out with E. coli
polymerase I. The assay condition was as described in
the procedure provided by the supplier (Bethesda Re-
search Laboratory, Rockville, MD). Briefly, cold dATP,
dGTP, TTP (at a final concentration of 10-4 M) and 10
fiCi of [32P]dCTP (3000 Ci/mm; Amersham, Arlington
Hts., IL) were used in 100 ,uL assay volume containing
5 ,ug oftemplate DNA. At specified times 5 ,L sample
was withdrawn, precipitated in 10% trichloroacetic acid
(TCA) on nitrocellulose filter at 0°C. The filter was
washed extensively with 10,000 volumes ofcold 5% TCA,
then with 80% ethanol; it was then dried and counted
by a liquid scintillation method.
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Results
Kinetics of [3H]AFB1 Binding to HMW
DNAs
Aflatoxin B1 binds efficiently to all the HMW DNAs
tested. Figure 1 shows the kinetics of[3H]AFB1 binding
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FIGURE 1. Kinetics of['H]AFB1 binding to various high molecular
weight DNAs prepared from (e) normal adult liver; (A) primary
carcinoma cell (PLC); (A) Mahlavu hepatocellular carcinoma cell
(hHC); (0) nonhuman DNA from NIH/3T3 mouse fibroblasts.
[3H]AFB1 was activated and bound to HMW DNA as described
in the text in a final volume of 1.0 mL. Aliquots, 5 ,uL containing
1.0 ,g of HMW DNA were withdrawn and TCA precipitated on
nitrocellulose filter. Samples werewashed extensively with 10,000
volumes of ice-cold chloroform. The amount of [3H]AFB1 bound
to DNA on the filter was then determined by a liquid scintillation
method (11).YANG ET AL.
to human HMW DNAs prepared from a normal adult
liver, primary carcinoma cell (PLC), and Mahlavu he-
patocellular carcinoma cell (hHC). Binding to one non-
human DNA obtained from NIH/3T3 mouse fibroblasts
was also analyzed. It is apparent that the initial rates
of AFB1 binding to all these DNAs were extremely
rapid and linear although the extent of AFB1 binding
might be slightly higher with PLC and Mahlavu hHC
DNAs.
Preferential Binding of Subgenomic DNA
Fragments by [3H]AFB1
High molecular weight DNAs prepared from normal
adult liver and from Mahlavu hepatocellular carcinoma
cells, bound to [3H]AFB1 at saturation level, were ex-
haustively washed free of unbound AFB1 with chloro-
form prior to ethanol precipitation. The [3H]AFB,-DNAs
were subjected to various restriction endonuclease
digestions. Among the numerous restriction endonu-
cleases tested on the human HMW DNAs in this study
which included Eco RI, Bam HI, Hind III, Pst I, Kpn
I, Alu I, Hae III, and Taq I, Hind III restriction yielded
the mostinformative pattern. Figure2showstheprofile
of the Hind III restricted [3H]AFB1-DNAs of normal
adult liver as compared to that of Mahlavu hHC HMW
DNA when analyzed in agarose gel electrophoresis.
Taking the DNA concentration at A260 into considera-
tion, preferential binding ofthe Hind III restricted hHC
subgenomic DNA fragments by [3H]AFB1 are evident
at the following peaks: (1) >12 kb; (2) 2.6-3.2 kb; (3)
1.4-1.8 kb; (4) 500-650 bp; (5) 350 bp; and (6) 50-100
bp, which showed considerably high specific activities
of [3H]AFB,cpm/Ipg of DNA. Normal adult liver DNA
showed mostbinding atthehighmolecularweightband,
> 12 kb, with little binding at the 1.4-3.2 kb regions.
Considerable bindingatthe 50-100bp, 350bp, and 500-
650 bp was seen in both samples. These represented
the human repetitive Alu I/Hae III sequence when ana-
lyzed by hybridization against the [32P] nick-translated
Alu I/Hae III human DNA (14) which is rich in GC
contents (data not shown).
Dose Effect of [3H]AFB1 Binding in the
Activation of a Human Proto-Oncogene
It has recently been reported that chemical carcino-
gen could activate a proto-oncogene and render it ca-
pable ofcell transformation when assayed by the DNA-
mediated cell transformation assay in suitable indicator
cells (15). We had also examined the capability of the
AFB1-bound HMW DNA prepared from Mahlavu he-
patocellular carcinoma cells at various [3H]AFB1 con-
centrations to transform NIH/3T3 cells. As controls, we
chose normal adult liver DNA and NIH/3T3 cell DNA,
with or without [3H]AFB1 binding. Table 1 summarizes
the[3H]AFB1 bindingtothevarious DNAs atincreasing
concentrations and the number oftransformed foci per
10 ,ug of [3H]AFB,-DNA obtained in the DNA-me-
diated cell transformation assay. AFB1 bound all tested
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FIGURE 2. Electrophoretic patterns of[3H]AFB,-bound DNAs pre-
pared from normal adult liver and from Mahlavu hepatocellular
carcinoma cell. Approximately 20 jig of [3H]AFB1-DNA was di-
gested with Hind III restriction endonuclease prior to its analysis
in agarose gel (1.0%) electrophoresis. Details of all procedures
were as described in "Materials and Methods."
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FIGURE 3. Dose dependency of[3H]AFB, activation ofMahlavu he-
patocellularcarcinoma DNAin DNA-mediated celltransformation
study. All experimental procedures were as described in Table 1.
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HMW DNAs prepared from normal adult liver (NAL),
Mahlavu hHC, and NIH/3T3 cells equally well. How-
ever, it is evident that, within a narrow dosage range,
AFB1 activated only the HMW DNA from Mahlavu hHC
cells and rendered the hHC HMW DNA capable of
transforming NIH/3T3 cells in the transfection assay
(Fig. 3). These critical doses range from 100 to 460
fmole/pug HMW DNA. In contrast, AFB1 binding did
not render the HMW DNA from the other sources (NAL
and NIH/3T3) capable of cell transformation.
The addition ofTPA to the transfected NIH/3T3 cul-
tures did not increase the number of transformed foci
in the assay (Table 1). On the other hand, it seemed to
augment the carcinogenic effect ofthe mutagenic AFB1
bound hHC DNAinthe transfection assay. Focal trans-
formationappeared earlierby2to3daysinthepresence
of TPA, and the foci appeared larger and more promi-
nent. Similar to observations reported elsewhere (10,16),
TPA was thus considered a promotor and not an initi-
ator in this study.
The transformed cells were successfully cloned by
penny-cylinder, and DNAwas extractedfromthetrans-
fected clones for verifying the integration of the hHC
AFB1-DNAinthe mouse cell's genome. Figure4 shows
the Southern blot hybridization of the purified trans-
fectantDNAsfromvarioustransformed clones andfrom
other transfected cultures, that showed no transfor-
mation, against [2P] nick-translated Mahlavu hHC DNA
digested by Hind III restriction endonuclease. Clones
1 and 2 showed 4.8 and 1.2 focus-forming units (FFU)
per 10 ,ug of the transfectant DNA hybridization with
the 2P] hHC DNA probe, integrated within the NIH/
3T3 mouse cell DNA. Other negative cultures of NIH/
3T3 cells that did not exhibit any focal transformation
at the end ofthe transfection assay were also cultured
out for DNA isolation for hybridization analysis. As
expected, no human DNA was detected in clones 3
transfected by [3H]AFB1-DNA of NIH/3T3 cells. The
negative cultures (4, 5, 6) transfected with [3H]AFB,
activated hHC DNAs at high doses ofAFB1, however,
did showpositiveintegration ofhHC DNAwhenprobed
with the [32P]-labeled hHC DNA restricted with Hind
III. The human DNAs, however, did not show identi-
fiable bands as in clones 1 and 2, but rather diffused
patterns. The transformed phenotype was thus most
probablyconferredbytheexogenoushuman[3H]AFB1-
DNA activated at an optimal dosage withoutdisruption
of the molecular integrity of the hHC DNA in the re-
cipient NIH/3T3 mouse cells. We further examined if
the exogenous human DNA was stably integrated into
the mouse cell DNA by a secondary transfection assay
using the transfectant DNA on NIH/3T3 cells. Results
(not shown) showed an increase in the efficiency ofthe
tranfectant DNA in transforming NIH/3T3 cells.
Tumorigenicity of the Transformed NIH/
3T3 Cells Transfected with [3H]AFB1-DNA
of Mahlavu Hepatocellular Carcinoma Cell
The tumorigenicity ofthe transformed NIH/3T3 cells
Sources of
HMW DNA
NIH/3T3 cell
Human normal liver
Mahlavu
hepatocellular
carcinoma cell
[3H]AFB1 bound,
fmole/,Lg DNA
0
123
252
395
682
0
112
210
392
455
0
197
248
273
403
843
867
DNA-mediated
focal transformation,
FFU/10 Lg of
[3H]AFB1-DNA
No TPA Plus TPA
0
o 0
o 0
o 0
o 0
o 0
o 0
o 0
o 0
o 0
o 0
4.8 4.1
0.9 1.0
0.4 0.2
0.1 0
0 0
o 0
a[3H]AFBI was activated and bound to HMW DNA as described
in the text in a final volume of 1.0 mL. Aliquots, 5 p1L containing 1.0
,ug of HMW DNA, were withdrawn and TCA precipitated on nitro-
cellulosefilter. Samples werewashedextensivelywith 10,000volumes
of ice-cold chloroform. The amount of [3H]AFB1 bound to DNA on
the ifiter was then determined by a liquid scintillation method (11).
Simultaneous samples of50 ,uL each, containing 10 ,ugofHMW DNA,
were withdrawn and precipitated in ethanol-NaCl. The [3H]AFB1-
DNA in these samples were prepared and used in cell transformation
studybyDNAtransfection assay asdescribedin"MaterialsandMeth-
ods."
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AFB,HC DtNA
fmole/ug 35
AFB-NIH/3JT3DNA
fmole/ug
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FIGURE 4. Detection of human HMW DNA in transformed clones
and in transfected, nontransformed cultures of NIH/3T3 cell by
Southern blot, DNA-DNA hybridization analysis. DNAs were
isolated from the transformed clones and from transfected, non-
transformed cultures of NIH/3T3 cell. Approximately 10 ,ug of
DNA was used in each sample for hybridization. Approximately
2 x 106 cpm of[32P]-nick-translated hHC DNA per filter was used
in hybridization. All experimental procedures and conditions were
as described in "Materials and Methods."
Table 1. Activation of carcinogenic activity of human high
molecular weight DNA by binding with aflatoxin Bj.'
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FIGURE 5. Tumorigenesis oftransforned NIH/3T3 cellstransfected
by Mahlavu hepatocellular carcinoma DNA in nude mice: (a) )tu-
mor developed in nude mouse inoculated with 106 transformed
NIH/3T3cells transfected with Mahlavu hHC [3H]AFB,-DNA; (b)
nude mouse inoculated with 106 transfected NIH/3T3 cells trans-
fected with [3H]AFB1-DNA of NIH/3T3. All procedures were as
described in "Materials and Methods."
transfected by the [3H]AFB1-hHC DNA was also ex-
amined by injecting 106 transformed cells each from
clone 1 and clone 2 into NIH Swiss nude mice. Similarly,
a tumorigenicity test was also carried out with trans-
fected culturesthat did not show anytransformed focus.
Within 3 weeks a tumor developed in nude mice at the
site ofinoculation with clone 1- and clone 2-transformed
cells (Fig. 5) but not in mice inoculated with the tran-
fected cells which showed no transformed foci. These
tumors were eventually successfullly passed in NIH Swiss
mice but not in Balb/c mice.
On the basis ofthese observations we have concluded
that aflatoxin B1, at an optimal range of dosage, prob-
ably activated a human proto-oncogene in the HMW
DNA of Mahlavu hHC cells, rendering it capable of
transforming cells and tumorigenesis.
Overkill Effect of Excessive [3H]AFB,
Binding on HMW DNA
Excessive AFB1 binding on HMW hHC DNA abol-
ished all biological transformation capability such as ob-
served in samples with greater than 450 fmole ofAFB1
bound/,ug of the HMW hHC DNA (Fig. 3). In the four
samples with binding of AFB1 at 520, 745, 1550, and
1600 fmole/,ug ofHMW hHC DNA, no transformed foci
were observed, although human HMW DNA was ap-
parently detectable in these cultures when examined by
DNA-DNA hybridization analysis as discussed above
(Fig. 4). When the biochemical parameter oftemplating
capability of the DNAs bound with AFB1 at varying
doses was examined, an inverse relationship seemed to
exist between increasing dosage ofAFB1 bound and the
templating activity of AFB1-DNA. Figure 6 shows a
progressive loss of templating capability of the HMW
DNA with increasing binding by [ H]AFB1 in DNA po-
lymerase assays using E. coli DNA polymerase. We
also obtained the same results in RNA polymerase as-
says (data not shown). When the products synthesized
intheDNApolymerasereaction, using[3H]AFB1-DNA
at 1462 fmole/,ug DNA as template, were examined,
short and heterogeneous fragments ranging from 20 to
100 nucleotides were obtained when determined by po-
lyacrylamide gel (4%) electrophoresis (data not shown).
Excessive binding of the AFB1 on HMW DNA thus
impaired the templating capability of the HMW DNA.
AFB1 covalently linked to the N7 of the guanine of the
DNA seemed to have caused the newly synthesized po-
lynucleotide strand to terminate prematurely, so that
only short polynucleotide products were synthesized in
the DNA polymerase reaction.
Discussion
Other reports (7,8,12,17) and our current investiga-
tion demonstrated that aflatoxin B1, when activated
chemically or by microsomal oxidases to become the
AFB,-2,3-epoxide, tendstobind DNAefficiently. Inour
binding studies, [3H]AFB1 bound hepatocellular carci-
noma DNA, digested with Hind III, at a differential
pattern than that of young adult liver DNA. Prefer-
entialbindingwas observed withthe hepatocellular car-
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FIGURE 6. Template activity of[3H]AFBI-bound DNA ofprimary
liver carcinoma (Alexander) cell: (a) PLC DNA with no aflatoxin
binding; (b) PLC DNA bound with 152 fmole of[3H]AFB,; (c) PLC
DNA bound with 3100 fmole of[3H]AFB,. DNA polyrnerase assay
was as described in Methods. A 5-,uL sample of[31P]dCTP labeled
product was precipitated in lO0o ice-cold TCA on nitrocellulose
filter. The filter was washed extensively and counted by a liquid
scintillation method as described in the "Materials and Methods."
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cinoma DNA at two subgenomic, Hind III restricted
DNA fragments: 1.4 to 1.8 kb and 2.6 to 3.2 kb (Fig.
2). In contrast, normal adult liver DNA showed little
or no bindingby [3H]AFB1 in DNA fragments ofsimilar
sizes when examined in the same experiment. Similar
[3H]AFB1 preferential binding patterns were seen in
both hepatocellular carcinoma DNA as well as young
normal liver DNA at subgenomic DNA fragments of50
to 150 bp, 300 to 350 bp, and 500 to 650 bp. These
probably corresponded to the human Alu I/Hae III re-
petitive sequences which are rich in GC contents (data
not shown).
The binding of [3H]AFB1 on Mahlavu HMW DNA at
optimal dosage of 100 to 460 fmole/,Lg DNA activated
a proto-oncogene in the hHC HMW DNA, which dem-
onstrated cell-transformation capability in transfection
assay on NIH/3T3 cells (Fig. 3). It should be mentioned
that, in the current study, total high molecular weight
DNA (> 25 kb) was used in all experiments; thus the
optimal AFB1 binding dosage may be much higher than
the optimal dosage required for a molecularly cloned
proto-oncogene ofmolecular size ofafewkilobase pairs.
Itwillbeespeciallymeaningfulto determine the optimal
dosage necessary for AFB1 activation ofahuman proto-
oncogene with a known molecular size.
Excessive binding by [3H]AFBI on Mahlavu HMW
hHC DNAnotonlyfailedtoactivate theproto-oncogene
but also diminished the template capability ofthe HMW
DNA. In short an "overkill" effect in both DNA-me-
diated cell transformation and DNA templating capa-
bility was seen with excessive binding ofAFB1 on HMW
DNA.
It has been well documented that aflatoxin B1 is a
potent hepatocarcinogen (1,3,4). Its mechanism of ac-
tion has yet to be well understood. Our current study
and others suggested that one possible mode ofaflatoxin
B1 action resides in its affinity to form covalent linkage
with the N7 ofguanine in high molecular weight DNA.
As discussed above, preferential targetswithin the high
molecular weight DNA were evident in our analysis
with the Hind III digested [3H]AFB1-DNA from Mah-
lavu hHC cell. Others have suggested in their reports
(18,19)- and our results in preliminary examinations
on the nucleotide sequences targeted by AFB,- indi-
cated that AFB1 attack on guanine is greatly affected
by the vicinal nucleotide sequence. Among the pre-
ferred AFB1 targets, we have obtained a 3.1 kb Hind
III restriction fragment ofMahlavu hHC DNA, in which,
we have established a Nar I restriction endonuclease
site reading GCCGGC. The Nar I restriction endonu-
clease recognition sequence has been considered a di-
agnostic sequence for the 12th amino acid (GGC), glycine,
ofthe n-ras oncogene family (20). In bladder carcinoma
such a sequence has been mutated to GCCGTC, and
thus the 12th amino acid was replaced by valine (GTC)
(20). In our nucleotide sequence analysis, as well as
suggested by others (18), AFB1 shows high affinity with
the second G in atetranucleotide ofCGGC. AFB1 bound
to the N7 ofguanine was reported to render the AFB,-
Gincapable ofbase-pairingwith C butrathermispairing
with A thus resulting in a (G-C to A-T) transversion
type of mutation (21). Whether a similar event has oc-
curred in the HMW DNA of Mahlavu hepatocellular
carcinoma cell upon AFB, binding at optimal concen-
tration, awaits further detailed nucleotide sequence
analysis.
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